Educational resources

This section includes resources developed by Guidelines, including algorithms, medicines appraisal cards, supplements, and videos. Items may contain pharmaceutical promotional information.

Webinar banner 3x22

Non-alcoholic steatohepatitis: identification, management, and referral pathways

Commissioned by Intercept Pharma UK and Ireland Ltd

The content on this page is intended for UK healthcare professionals only.

Su Down video image

Identification of pancreatic exocrine insufficiency (PEI) in patients with diabetes

Commissioned by Viatris

In this video, Su Down looks at the identification of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3287 December 2020

Mike Cummings video 1 image

Assessment of pancreatic exocrine insufficiency (PEI) in primary care

Commissioned by Viatris

In this video, Professor Michael Cummings looks at the assessment of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3288 December 2020

Mike Cummings video 2 image

Management of pancreatic exocrine insufficiency (PEI) in primary care

Commissioned by Viatris

In this video, Professor Michael Cummings looks at the management of PEI in patients with diabetes.
This video has been commissioned and funded by Viatris and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.

NON-2020-3289 December 2020

index

Management of common eye conditions: blepharitis

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) explains the symptoms and management of blepharitis.

index 2

Management of common eye conditions: conjunctivitis

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) describes the causes, symptoms, and treatment of conjunctivitis.

dry eye index image

Management of common eye conditions: dry eye

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) covers the presentation, causes, and treatment of dry eye.

foreign bodies index image

Management of common eye conditions: corneal and subtarsal foreign bodies

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) covers the symptoms and treatment of foreign bodies in the eye.

chalazion index image 2

Management of common eye conditions: chalazion (meibomian cyst)

Funded by Allergan plc

Fiona Chiu (Moorfields Eye Hospital NHS Foundation Trust) describes the presentation and management of chalazion (meibomian cyst).

index image

Management of common eye conditions: corneal abrasion

Funded by Allergan plc

Sarah Thomas (Moorfields Eye Hospital NHS Foundation Trust) discusses the causes, symptoms, and treatment of corneal abrasion.

Promotional content


Twitter ClinOwl

ClinOwl - A new resource for healthcare professionals

Promotional material from ClinOwl Ltd

A free resource, which aggregates and curates the latest clinical articles from leading medical journals in a single view. Keep up to date quickly and easily. You will be redirected to ClinOwl.com.

Front cover image 20201209 Saxenda TA card V4 digital version

NICE Technology Appraisal 664: Liraglutide for managing overweight and obesity

Commissioned by Novo Nordisk Limited

The production and printing of this Guidelines summary card has been commissioned by Novo Nordisk Ltd. Information intended for UK healthcare professionals only. 
View prescribing information
UK20SX00231
December 2020

20201002 Rizmoic TA card V5 image

NICE Technology Appraisal 651: Naldemedine ▼ for treating opioid‑induced constipation

Commissioned by Sandoz Limited

The production and printing of this Guidelines summary card has been commissioned by Sandoz Ltd. Information intended for UK healthcare professionals only.
View prescribing information

UK/P/RZM/20-0016c October 2020

Mylan HRT evidence update cover

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

Funded by Mylan

Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.

FINAL DuoResp prescribing summary card image6

DuoResp® Spiromax® (budesonide/formoterol)

Commissioned by Teva UK Limited

This promotional prescribing summary card has been developed from content provided by Teva UK Limited. Information intended for UK healthcare professionals only. 
Click here for prescribing information and adverse event reporting.
DUOR-GB-00021
Date of preparation: August 2020

GSK logo

COPD: LAMA/LABA as initial maintenance therapy for appropriate symptomatic patients

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200014 V2.0

GSK logo

COPD: LAMA/LABA therapy—Real life case studies

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200015 V2.0

GSK logo

Why you might want to review patients with COPD receiving a LAMA

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200013

GSK logo

COPD: Have you done enough to implement guidelines?

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200012

GSK logo

Why use LAMA/LABAs as initial maintenance therapy in specific COPD patients?

Content funded and provided by GSK

This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200011

Stack of fruits, white weight scale and tailor meter on wooden board_AS

Managing obesity in primary care

By Development Group—Tahrani Parretti O’Kane Chowhan Ratcliffe and Le Brocq

This management algorithm was developed by a multidisciplinary expert panel: Tahrani et al with the support of an educational grant from Novo Nordisk Limited. Information intended for UK healthcare professionals.

FINAL IDA algorithm index image

Primary care management of iron deficiency anaemia

Commissioned by Norgine Pharmaceuticals Limited

This management algorithm has been commissioned and funded by Norgine Pharmaceuticals Ltd and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
UK-HAE-FER-2000063

Anticholinergics and OAB algorithm

Anticholinergics and cognitive impairment in the treatment of overactive bladder

Commissioned by Contura Ltd

This management algorithm has been commissioned and funded by Contura Ltd and developed in partnership with Guidelines. Information intended for UK healthcare professionals.
View adverse event reporting and prescribing information

REG/2020/224 September 2020

AdobeStock_212764468

Identifying and managing allergic rhinitis in the asthma population

By Development Group—Scadding Holmes Ryan and Williams

This management algorithm was developed by a multidisciplinary expert panel: Scadding et al with the support of an educational grant from Mylan.

X-ray (female pelvis) 397x302

Osteoporotic fracture guideline

By Working party—Cooper Javaid Elliott Stephens Tanna

This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of an educational grant from UCB Pharma Ltd.

DVT and PE_prescribers checklist

Xarelto▼ (rivaroxaban) patient counselling checklist for HCPs—initiating, or transitioning to rivaroxaban for eligible patients with DVT or PE*

Commissioned by Bayer plc

This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines. Information intended for healthcare professionals only.
View prescribing information and adverse event reporting information
*Rivaroxaban is indicated for treatment of DVT and  PE, and prevention of recurrent DVT and PE in adults.

PP-XAR-GB-1856  November 2020

Pharmacist NVAF counselling checklist_interactive PDF

Community Pharmacist Counselling Checklist for patients with NVAF initiated on Xarelto▼ (rivaroxaban)

Commissioned by Bayer plc

This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines for Pharmacy. Information intended for healthcare professionals only.
View prescribing information and adverse event reporting information

PP-XAR-GB-1857  November 2020

NVAF prescribers checklist

Xarelto▼ (rivaroxaban) patient counselling checklist for HCPs—initiating, or transitioning to rivaroxaban for stroke prevention in patients with NVAF*

Commissioned by Bayer plc

This checklist was developed from content provided by Bayer plc and the format was developed by Guidelines. Information intended for healthcare professionals only.
View prescribing information and adverse event reporting information
*Rivaroxaban is indicated for prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack.

PP-XAR-GB-1858  November 2020